Concomitant treatment with insulin and sodium-glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score-matched analysis.

Masao ToyodaNobumichi SaitoMoritsugu KimuraNobuo HatoriKouichi TamuraMasaaki MiyakawaKazuyoshi SatoAkira KanamoriKazuo Kobayashi

Published in: Journal of diabetes investigation (2022)

Concomitant administration of IT with SGLT2is influenced the RCO in Japanese patients with type 2 diabetes mellitus and chronic kidney disease. We might need to consider the influence of concomitant agents on the renoprotective effects of SGLT2i therapy.

Keyphrases

chronic kidney disease
end stage renal disease
type diabetes
stem cells
glycemic control
adipose tissue
skeletal muscle
metabolic syndrome
mesenchymal stem cells
combination therapy
insulin resistance
replacement therapy
weight loss
data analysis